Novacept Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $325M

Novacept General Information

Description

Developer of medicine meant for the treatment of menstrual bleeding. The company designs, develop, manufacture and market innovative therapeutic medical devices to improve the quality and cost-effectiveness of women's healthcare.

Contact Information

Website
www.novacept.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1047 Elwell Court
  • Palo Alto, CA 94303
  • United States
+1 (650)
Primary Industry
Therapeutic Devices
Acquirer
Cytyc
Vertical(s)
Manufacturing
Corporate Office
  • 1047 Elwell Court
  • Palo Alto, CA 94303
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novacept Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 26-Mar-2004 $325M Completed Clinical Trials - General
5. IPO 24-Mar-2004 Cancelled Clinical Trials - General
4. Later Stage VC 26-Dec-2003 Completed Clinical Trials - General
3. Later Stage VC (Series H) 16-May-2002 Completed Generating Revenue
2. Later Stage VC 01-Jan-2001 $25.4M $40.7M Completed Generating Revenue
1. Later Stage VC (Series G) 02-Apr-2001 $15.3M $15.3M Completed Generating Revenue
To view Novacept’s complete valuation and funding history, request access »

Novacept Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Novacept Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2002239929-A1 Apparatus and method for treating venous reflux Inactive 16-Jan-2001
WO-2002056772-A2 Apparatus and method for treating venous reflux Inactive 16-Jan-2001
WO-2002056772-A3 Apparatus and method for treating venous reflux Inactive 16-Jan-2001
DE-60018478-D1 Flat knitting machine and knitting process Inactive 14-Feb-2000
DE-60018478-T2 Flat knitting machine and knitting process Inactive 14-Feb-2000 D04B15/90
To view Novacept’s complete patent history, request access »

Novacept Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Band of Angels Angel Group Minority
Brentwood Venture Capital Venture Capital Minority
Fitch Group (Other Financial Services) Corporation Minority
ITX (US) Corporation Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Novacept FAQs

  • When was Novacept founded?

    Novacept was founded in 1995.

  • Where is Novacept headquartered?

    Novacept is headquartered in Palo Alto, CA.

  • What industry is Novacept in?

    Novacept’s primary industry is Therapeutic Devices.

  • Is Novacept a private or public company?

    Novacept is a Private company.

  • What is the current valuation of Novacept?

    The current valuation of Novacept is .

  • What is Novacept’s current revenue?

    The current revenue for Novacept is .

  • How much funding has Novacept raised over time?

    Novacept has raised $73M.

  • Who are Novacept’s investors?

    Band of Angels, Brentwood Venture Capital, Fitch Group (Other Financial Services), ITX (US), and Johnson & Johnson JJDC are 5 of 14 investors who have invested in Novacept.

  • When was Novacept acquired?

    Novacept was acquired on 26-Mar-2004.

  • Who acquired Novacept?

    Novacept was acquired by Cytyc.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process